192 related articles for article (PubMed ID: 26884871)
21. Clinical and pathological characteristics and their effect on survival in elderly patients with gastrointestinal stromal tumors.
Molinas Mandel N; Selcukbiricik F; Kanitez M; Yalcin S; Tural D; Erdamar S; Dogusoy G; Demir G
J BUON; 2016; 21(2):360-5. PubMed ID: 27273945
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Relevance of p53 Overexpression in Gastrointestinal Stromal Tumors of the Small Intestine: Potential Implication for Adjuvant Treatment with Imatinib.
Yoo C; Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S362-9. PubMed ID: 25791792
[TBL] [Abstract][Full Text] [Related]
23. Cytoreductive Surgery for Metastatic Gastrointestinal Stromal Tumors Treated With Tyrosine Kinase Inhibitors: A 2-institutional Analysis.
Fairweather M; Balachandran VP; Li GZ; Bertagnolli MM; Antonescu C; Tap W; Singer S; DeMatteo RP; Raut CP
Ann Surg; 2018 Aug; 268(2):296-302. PubMed ID: 28448384
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis.
Ouyang J; An T; Wang Y; Lu X; Zhang Y; Wang X; Zhang X; Zhang C
Diagn Pathol; 2021 Dec; 16(1):113. PubMed ID: 34895274
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal stromal tumors: prognostic factors and therapeutic implications.
Rosa F; Alfieri S; Tortorelli AP; Di Miceli D; Papa V; Ricci R; Doglietto GB
Tumori; 2012; 98(3):351-6. PubMed ID: 22825511
[TBL] [Abstract][Full Text] [Related]
26. Relationship between R1 resection, tumour rupture and recurrence in resected gastrointestinal stromal tumour.
Hølmebakk T; Bjerkehagen B; Hompland I; Stoldt S; Boye K
Br J Surg; 2019 Mar; 106(4):419-426. PubMed ID: 30507040
[TBL] [Abstract][Full Text] [Related]
27. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
Corless CL; Ballman KV; Antonescu CR; Kolesnikova V; Maki RG; Pisters PW; Blackstein ME; Blanke CD; Demetri GD; Heinrich MC; von Mehren M; Patel S; McCarter MD; Owzar K; DeMatteo RP
J Clin Oncol; 2014 May; 32(15):1563-70. PubMed ID: 24638003
[TBL] [Abstract][Full Text] [Related]
28. Resection of liver metastases in patients with gastrointestinal stromal tumors in the imatinib era: A nationwide retrospective study.
Seesing MF; Tielen R; van Hillegersberg R; van Coevorden F; de Jong KP; Nagtegaal ID; Verhoef C; de Wilt JH;
Eur J Surg Oncol; 2016 Sep; 42(9):1407-13. PubMed ID: 27038995
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of Long-Term Adjuvant Therapy With Imatinib Mesylate After Extensive Surgical Treatment for Ruptured Gastrointestinal Stromal Tumors of the Small Intestine With Peritoneal Metastases: A Case Report.
Kimura T; Togawa T; Onishi K; Iida A; Sato Y; Goi T
J Investig Med High Impact Case Rep; 2020; 8():2324709620970736. PubMed ID: 33228387
[TBL] [Abstract][Full Text] [Related]
30. Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG
JAMA Surg; 2020 Jun; 155(6):e200397. PubMed ID: 32236507
[TBL] [Abstract][Full Text] [Related]
31. Is there a role of surgery in patients with recurrent or metastatic gastrointestinal stromal tumours responding to imatinib: a prospective randomised trial in China.
Du CY; Zhou Y; Song C; Wang YP; Jie ZG; He YL; Liang XB; Cao H; Yan ZS; Shi YQ
Eur J Cancer; 2014 Jul; 50(10):1772-1778. PubMed ID: 24768330
[TBL] [Abstract][Full Text] [Related]
32. Retrospective analysis of 85 cases of intermediate-risk gastrointestinal stromal tumor.
Fu Y; Hao H; Guo L; Yang G; Zhang X
Oncotarget; 2017 Feb; 8(6):10136-10144. PubMed ID: 28052037
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study.
Mohammadi M; IJzerman NS; Hohenberger P; Rutkowski P; Jones RL; Martin-Broto J; Gronchi A; Schöffski P; Vassos N; Farag S; Baia M; Oosten AW; Steeghs N; Desar IME; Reyners AKL; van Sandick JW; Bastiaannet E; Gelderblom H; Schrage Y
Eur J Surg Oncol; 2021 Aug; 47(8):2173-2181. PubMed ID: 33895019
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms in angiogenesis-related genes are associated with worse progression-free survival of patients with advanced gastrointestinal stromal tumours treated with imatinib.
Verboom MC; Kloth JSL; Swen JJ; van der Straaten T; Bovée JVMG; Sleijfer S; Reyners AKL; Mathijssen RHJ; Guchelaar HJ; Steeghs N; Gelderblom H
Eur J Cancer; 2017 Nov; 86():226-232. PubMed ID: 29054076
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
36. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
Qu WZ; Wang L; Chen JJ; Wang Y
World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
[TBL] [Abstract][Full Text] [Related]
37. Predictors of recurrence after resection of small gastric gastrointestinal stromal tumors of 5 cm or less.
Kim MY; Park YS; Choi KD; Lee JH; Choi KS; Kim DH; Song HJ; Lee GH; Jung HY; Kim JH; Yun SC; Kim KC; Yook JH; Oh ST; Kim BS; Ryu MH; Kang YK
J Clin Gastroenterol; 2012 Feb; 46(2):130-7. PubMed ID: 21617541
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological Outcomes and Prognosis of Elderly Patients (≥ 65 Years) with Gastric Gastrointestinal Stromal Tumors (GISTs) Undergoing Curative-Intent Resection: a Multicenter Data Review.
Yang Z; Feng X; Zhang P; Chen T; Qiu H; Zhou Y; Du C; Yin X; Pan F; Zheng G; Liu X; Huang C; Zhou Z; Li G; Tao K; Li Y
J Gastrointest Surg; 2019 May; 23(5):904-913. PubMed ID: 30324400
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of Atoh1 correlates with favorable survival in gastrointestinal stromal tumor.
Huang H; Zhai X; Zhu H; Wang W; Zhang S; Wu L; Zhang J
Int J Clin Exp Pathol; 2014; 7(10):7123-30. PubMed ID: 25400808
[TBL] [Abstract][Full Text] [Related]
40. Surgical management of gastrointestinal stromal tumours: a single centre experience during the past 17 years.
De Vogelaere K; Van De Winkel N; Aerts M; Haentjens P; Spitali C; Van Loo I; Delvaux G
Acta Chir Belg; 2014; 114(3):167-73. PubMed ID: 25102705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
